Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
97 hedge funds and large institutions have $20.8M invested in Zomedica Corp. in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 26 closing their positions.
12% less funds holding
Funds holding: 110 → 97 (-13)
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
46% less capital invested
Capital invested by funds: $38.3M → $20.8M (-$17.5M)
50% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$883K |
| 2 |
Renaissance Technologies
New York
|
+$638K |
| 3 |
Jane Street
New York
|
+$222K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$193K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$126K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$3.92M |
| 2 |
Swiss National Bank
Zurich,
Switzerland
|
-$742K |
| 3 |
BlackRock
New York
|
-$526K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$455K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$265K |
ZOM Hedge Fund Activity: Q2 2022 in Review
97 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2022, worth a combined $20.8M — down 46% from $38.3M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of ZOM and 13 opened new positions — a net loss of 13 holders — while 24 trimmed existing stakes and 17 added.
The largest buyer was Vanguard Group, adding an estimated $883K. The largest seller was State Street, cutting an estimated $3.92M.
- 97 institutional investors held Zomedica Corp. (ZOM) as of Q2 2022, down from 110 in Q1 2022.
- Funds reported $20.8M of Zomedica Corp. stock for Q2 2022, down 46% quarter-over-quarter.
- 13 funds opened new Zomedica Corp. positions in Q2 2022 and 26 closed out, a net change of -13 holders.
- The largest Zomedica Corp. buyer in Q2 2022 was Vanguard Group, an estimated $883K added.
- The largest Zomedica Corp. seller in Q2 2022 was State Street, an estimated $3.92M sold.
Based on aggregated 13F filings for Q2 2022.